| 0 |
ECZEMA COXSACKIUM |
1 |
0.5000 |
| 1 |
NAEVUS SPILUS |
1 |
0.1111 |
| 2 |
PERIPROCTITIS |
2 |
0.0625 |
| 3 |
SEVERE MYOCLONIC EPILEPSY OF INFANCY |
1 |
0.0323 |
| 4 |
LARYNGEAL ERYTHEMA |
1 |
0.0204 |
| 5 |
APPLICATION SITE ALOPECIA |
1 |
0.0182 |
| 6 |
SLEEP STUDY ABNORMAL |
1 |
0.0175 |
| 7 |
TYMPANIC MEMBRANE HYPERAEMIA |
1 |
0.0141 |
| 8 |
SPINAL CORD INJURY THORACIC |
1 |
0.0119 |
| 9 |
APPLICATION SITE HYPERAESTHESIA |
1 |
0.0101 |
| 10 |
PARAINFLUENZA VIRUS INFECTION |
1 |
0.0097 |
| 11 |
OVERGROWTH FUNGAL |
1 |
0.0097 |
| 12 |
POIKILODERMA |
1 |
0.0093 |
| 13 |
HYPERTROPHIC SCAR |
1 |
0.0092 |
| 14 |
METASTATIC UTERINE CANCER |
1 |
0.0085 |
| 15 |
MULTIPLE CHEMICAL SENSITIVITY |
1 |
0.0075 |
| 16 |
CONTRAINDICATION TO VACCINATION |
1 |
0.0052 |
| 17 |
MONONEUROPATHY |
1 |
0.0048 |
| 18 |
COLD URTICARIA |
1 |
0.0045 |
| 19 |
ACUTE MOTOR-SENSORY AXONAL NEUROPATHY |
1 |
0.0043 |
| 20 |
NAIL BED INFECTION |
1 |
0.0042 |
| 21 |
APPLICATION SITE BLEEDING |
1 |
0.0040 |
| 22 |
EYELID CYST |
1 |
0.0039 |
| 23 |
PARAPSORIASIS |
1 |
0.0037 |
| 24 |
PANCREATIC DUCT DILATATION |
1 |
0.0036 |
| 25 |
ECZEMA EYELIDS |
2 |
0.0036 |
| 26 |
EAR INFLAMMATION |
1 |
0.0035 |
| 27 |
MALABSORPTION FROM INJECTION SITE |
1 |
0.0032 |
| 28 |
FEMORAL ARTERY OCCLUSION |
1 |
0.0032 |
| 29 |
PERIORAL DERMATITIS |
2 |
0.0031 |
| 30 |
RIGHT VENTRICULAR ENLARGEMENT |
1 |
0.0031 |
| 31 |
DISCONTINUED PRODUCT ADMINISTERED |
1 |
0.0030 |
| 32 |
ECTROPION |
1 |
0.0030 |
| 33 |
CHOLURIA |
1 |
0.0029 |
| 34 |
PERIORBITAL IRRITATION |
1 |
0.0029 |
| 35 |
CHRONIC RESPIRATORY DISEASE |
1 |
0.0028 |
| 36 |
APPLICATION SITE PUSTULES |
1 |
0.0027 |
| 37 |
ERYTHROMELALGIA |
1 |
0.0027 |
| 38 |
FEEDING TUBE USER |
1 |
0.0027 |
| 39 |
KERATOCONUS |
1 |
0.0027 |
| 40 |
NASAL TURBINATE HYPERTROPHY |
1 |
0.0027 |
| 41 |
EYELID SKIN DRYNESS |
3 |
0.0025 |
| 42 |
HIGH FREQUENCY ABLATION |
1 |
0.0025 |
| 43 |
COLLAPSE OF LUNG |
2 |
0.0024 |
| 44 |
CANDIDA TEST POSITIVE |
1 |
0.0024 |
| 45 |
INFLUENZA A VIRUS TEST POSITIVE |
1 |
0.0023 |
| 46 |
REFLUX LARYNGITIS |
1 |
0.0023 |
| 47 |
DIVORCED |
1 |
0.0023 |
| 48 |
INFUSION SITE SCAR |
1 |
0.0023 |
| 49 |
DEGENERATIVE BONE DISEASE |
1 |
0.0023 |
| 50 |
BANKRUPTCY |
1 |
0.0022 |
| 51 |
ECZEMA HERPETICUM |
1 |
0.0022 |
| 52 |
PYOGENIC GRANULOMA |
1 |
0.0021 |
| 53 |
APPLICATION SITE ACNE |
1 |
0.0020 |
| 54 |
DRAINAGE |
1 |
0.0020 |
| 55 |
TONGUE ERUPTION |
1 |
0.0020 |
| 56 |
ORBITAL OEDEMA |
1 |
0.0020 |
| 57 |
CAPILLARY FRAGILITY |
1 |
0.0020 |
| 58 |
HYPERMETABOLISM |
1 |
0.0019 |
| 59 |
DANDRUFF |
4 |
0.0018 |
| 60 |
HYPERTENSIVE URGENCY |
1 |
0.0018 |
| 61 |
NAIL DYSTROPHY |
1 |
0.0018 |
| 62 |
SOFT TISSUE SWELLING |
1 |
0.0018 |
| 63 |
TONGUE HAEMORRHAGE |
2 |
0.0017 |
| 64 |
SKIN WEEPING |
6 |
0.0017 |
| 65 |
FAT NECROSIS |
1 |
0.0016 |
| 66 |
ALLERGY TO METALS |
1 |
0.0016 |
| 67 |
ELBOW OPERATION |
1 |
0.0016 |
| 68 |
ENTEROCOCCUS TEST POSITIVE |
1 |
0.0015 |
| 69 |
CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE |
1 |
0.0015 |
| 70 |
PRECANCEROUS CONDITION |
1 |
0.0015 |
| 71 |
REBOUND ECZEMA |
3 |
0.0015 |
| 72 |
ANGULAR CHEILITIS |
1 |
0.0014 |
| 73 |
APPLICATION SITE ULCER |
1 |
0.0014 |
| 74 |
ATROPHIC VULVOVAGINITIS |
1 |
0.0014 |
| 75 |
CONTRAINDICATION TO MEDICAL TREATMENT |
2 |
0.0013 |
| 76 |
ANTICOAGULATION DRUG LEVEL BELOW THERAPEUTIC |
1 |
0.0013 |
| 77 |
POLYCYSTIC OVARIES |
2 |
0.0013 |
| 78 |
INFECTION PARASITIC |
1 |
0.0013 |
| 79 |
BARRETT'S OESOPHAGUS |
1 |
0.0012 |
| 80 |
EXCESSIVE GRANULATION TISSUE |
1 |
0.0012 |
| 81 |
COMPULSIVE SEXUAL BEHAVIOUR |
1 |
0.0012 |
| 82 |
VACCINATION COMPLICATION |
1 |
0.0012 |
| 83 |
DERMAL CYST |
3 |
0.0012 |
| 84 |
GUTTATE PSORIASIS |
1 |
0.0012 |
| 85 |
TONGUE ERYTHEMA |
1 |
0.0012 |
| 86 |
HAND-FOOT-AND-MOUTH DISEASE |
1 |
0.0012 |
| 87 |
COVID-19 IMMUNISATION |
1 |
0.0012 |
| 88 |
CATHETER SITE PAIN |
3 |
0.0012 |
| 89 |
GENITAL BURNING SENSATION |
1 |
0.0012 |
| 90 |
LACK OF INJECTION SITE ROTATION |
2 |
0.0011 |
| 91 |
SKIN FISSURES |
22 |
0.0011 |
| 92 |
SOFT TISSUE INFECTION |
2 |
0.0011 |
| 93 |
BONE CONTUSION |
1 |
0.0011 |
| 94 |
URINARY TRACT INFECTION ENTEROCOCCAL |
1 |
0.0011 |
| 95 |
PNEUMONIA STAPHYLOCOCCAL |
2 |
0.0010 |
| 96 |
APPLICATION SITE SWELLING |
5 |
0.0010 |
| 97 |
SUSPECTED PRODUCT CONTAMINATION |
1 |
0.0010 |
| 98 |
CONJUNCTIVAL OEDEMA |
1 |
0.0010 |
| 99 |
URETEROLITHIASIS |
1 |
0.0010 |
| 100 |
SKIN SWELLING |
8 |
0.0009 |
| 101 |
BLADDER DILATATION |
1 |
0.0009 |
| 102 |
PRODUCT NAME CONFUSION |
1 |
0.0009 |
| 103 |
GRIP STRENGTH DECREASED |
8 |
0.0009 |
| 104 |
BLOOD TESTOSTERONE ABNORMAL |
1 |
0.0009 |
| 105 |
LIGAMENT INJURY |
1 |
0.0009 |
| 106 |
MOANING |
1 |
0.0009 |
| 107 |
CEREBRAL VENTRICLE DILATATION |
1 |
0.0009 |
| 108 |
CHEMICAL BURN |
1 |
0.0009 |
| 109 |
HAEMANGIOMA |
2 |
0.0009 |
| 110 |
OSTEOCHONDROSIS |
1 |
0.0009 |
| 111 |
SINUS PAIN |
2 |
0.0009 |
| 112 |
OTITIS EXTERNA |
1 |
0.0008 |
| 113 |
HELICOBACTER GASTRITIS |
1 |
0.0008 |
| 114 |
EYELID IRRITATION |
2 |
0.0008 |
| 115 |
APPLICATION SITE PARAESTHESIA |
1 |
0.0008 |
| 116 |
SCRATCH |
8 |
0.0008 |
| 117 |
GASTROENTERITIS NOROVIRUS |
1 |
0.0008 |
| 118 |
LIP EXFOLIATION |
1 |
0.0008 |
| 119 |
SKIN HAEMORRHAGE |
11 |
0.0007 |
| 120 |
SKIN DISCOMFORT |
2 |
0.0007 |
| 121 |
DERMATITIS ATOPIC |
39 |
0.0007 |
| 122 |
STENOTROPHOMONAS INFECTION |
1 |
0.0007 |
| 123 |
IMMUNOGLOBULINS DECREASED |
1 |
0.0007 |
| 124 |
APPLICATION SITE INFLAMMATION |
1 |
0.0007 |
| 125 |
SKIN HYPERTROPHY |
2 |
0.0007 |
| 126 |
TONIC CONVULSION |
1 |
0.0007 |
| 127 |
SEBORRHOEIC KERATOSIS |
1 |
0.0007 |
| 128 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
1 |
0.0007 |
| 129 |
NORMOCYTIC ANAEMIA |
1 |
0.0007 |
| 130 |
CONJUNCTIVITIS ALLERGIC |
1 |
0.0007 |
| 131 |
HAIR TEXTURE ABNORMAL |
9 |
0.0007 |
| 132 |
RUBBER SENSITIVITY |
1 |
0.0007 |
| 133 |
ONYCHOLYSIS |
1 |
0.0006 |
| 134 |
APPLICATION SITE PAIN |
14 |
0.0006 |
| 135 |
METABOLIC ALKALOSIS |
1 |
0.0006 |
| 136 |
STRONGYLOIDIASIS |
1 |
0.0006 |
| 137 |
SHOULDER FRACTURE |
1 |
0.0006 |
| 138 |
RECTAL ABSCESS |
1 |
0.0006 |
| 139 |
TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED |
1 |
0.0006 |
| 140 |
APPLICATION SITE DRYNESS |
2 |
0.0006 |
| 141 |
SKIN WOUND |
1 |
0.0006 |
| 142 |
GLIOBLASTOMA |
1 |
0.0006 |
| 143 |
LAZINESS |
1 |
0.0006 |
| 144 |
INJECTION SITE OEDEMA |
1 |
0.0006 |
| 145 |
CERVICAL SPINAL STENOSIS |
1 |
0.0006 |
| 146 |
SENSITIVITY OF TEETH |
1 |
0.0006 |
| 147 |
INFUSION SITE DISCHARGE |
1 |
0.0006 |
| 148 |
SKIN HYPOPIGMENTATION |
1 |
0.0006 |
| 149 |
ERYTHEMA OF EYELID |
3 |
0.0006 |
| 150 |
SUSPECTED PRODUCT QUALITY ISSUE |
1 |
0.0005 |
| 151 |
METAMORPHOPSIA |
1 |
0.0005 |
| 152 |
LOBAR PNEUMONIA |
1 |
0.0005 |
| 153 |
SKIN EXFOLIATION |
45 |
0.0005 |
| 154 |
NASAL OBSTRUCTION |
1 |
0.0005 |
| 155 |
PARANASAL SINUS DISCOMFORT |
2 |
0.0005 |
| 156 |
PANCREATIC CYST |
1 |
0.0005 |
| 157 |
NASAL SEPTUM DEVIATION |
1 |
0.0005 |
| 158 |
APPLICATION SITE RASH |
7 |
0.0005 |
| 159 |
HYPERAEMIA |
1 |
0.0005 |
| 160 |
DEVICE RELATED SEPSIS |
1 |
0.0005 |
| 161 |
DRY SKIN |
66 |
0.0005 |
| 162 |
DERMATITIS PSORIASIFORM |
1 |
0.0005 |
| 163 |
COMPULSIVE SHOPPING |
1 |
0.0005 |
| 164 |
RENAL MASS |
1 |
0.0005 |
| 165 |
ECZEMA |
25 |
0.0005 |
| 166 |
CATHETER SITE ERYTHEMA |
1 |
0.0005 |
| 167 |
CHAPPED LIPS |
2 |
0.0005 |
| 168 |
PRODUCT PREPARATION ISSUE |
3 |
0.0005 |
| 169 |
ONYCHOMYCOSIS |
2 |
0.0005 |
| 170 |
PRODUCT FORMULATION ISSUE |
3 |
0.0005 |
| 171 |
CALCINOSIS |
1 |
0.0004 |
| 172 |
PAIN OF SKIN |
12 |
0.0004 |
| 173 |
BLOOD LOSS ANAEMIA |
1 |
0.0004 |
| 174 |
EYELID DISORDER |
1 |
0.0004 |
| 175 |
FLAT AFFECT |
1 |
0.0004 |
| 176 |
NECK SURGERY |
1 |
0.0004 |
| 177 |
RESPIRATORY TRACT INFECTION VIRAL |
1 |
0.0004 |
| 178 |
FEAR OF INJECTION |
3 |
0.0004 |
| 179 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 180 |
LACUNAR INFARCTION |
1 |
0.0004 |
| 181 |
GUILLAIN-BARRE SYNDROME |
2 |
0.0004 |
| 182 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
7 |
0.0004 |
| 183 |
PHARYNGEAL SWELLING |
4 |
0.0004 |
| 184 |
DEVICE INFUSION ISSUE |
1 |
0.0004 |
| 185 |
APPLICATION SITE IRRITATION |
5 |
0.0004 |
| 186 |
DERMATOMYOSITIS |
1 |
0.0004 |
| 187 |
SKIN IRRITATION |
18 |
0.0004 |
| 188 |
AORTIC ARTERIOSCLEROSIS |
1 |
0.0004 |
| 189 |
MENOPAUSE |
1 |
0.0004 |
| 190 |
BLOOD CHLORIDE DECREASED |
1 |
0.0004 |
| 191 |
EYE PRURITUS |
13 |
0.0004 |
| 192 |
ACTINIC KERATOSIS |
1 |
0.0004 |
| 193 |
COMPARTMENT SYNDROME |
1 |
0.0004 |
| 194 |
PRODUCT ODOUR ABNORMAL |
4 |
0.0004 |
| 195 |
DERMATITIS |
8 |
0.0004 |
| 196 |
EXFOLIATIVE RASH |
1 |
0.0004 |
| 197 |
LUNG OPACITY |
1 |
0.0004 |
| 198 |
GAMBLING DISORDER |
1 |
0.0004 |
| 199 |
EAR CONGESTION |
1 |
0.0004 |
| 200 |
SKIN WRINKLING |
1 |
0.0004 |
| 201 |
APPLICATION SITE HAEMORRHAGE |
1 |
0.0004 |
| 202 |
RED BLOOD CELL COUNT INCREASED |
1 |
0.0004 |
| 203 |
ACUTE LYMPHOCYTIC LEUKAEMIA |
1 |
0.0004 |
| 204 |
OXYGEN SATURATION ABNORMAL |
1 |
0.0004 |
| 205 |
SCAB |
4 |
0.0004 |
| 206 |
EXERCISE TOLERANCE DECREASED |
2 |
0.0003 |
| 207 |
SKIN ATROPHY |
2 |
0.0003 |
| 208 |
PHARYNGEAL DISORDER |
1 |
0.0003 |
| 209 |
SKIN WARM |
2 |
0.0003 |
| 210 |
STRABISMUS |
1 |
0.0003 |
| 211 |
TOOTH DISCOLOURATION |
1 |
0.0003 |
| 212 |
BLOOD PRESSURE INADEQUATELY CONTROLLED |
2 |
0.0003 |
| 213 |
NEPHROGENIC SYSTEMIC FIBROSIS |
1 |
0.0003 |
| 214 |
INJECTION SITE VESICLES |
2 |
0.0003 |
| 215 |
MEDICAL DEVICE DISCOMFORT |
1 |
0.0003 |
| 216 |
DIASTOLIC DYSFUNCTION |
1 |
0.0003 |
| 217 |
TALIPES |
1 |
0.0003 |
| 218 |
HAIR COLOUR CHANGES |
4 |
0.0003 |
| 219 |
INJECTION SITE HYPERSENSITIVITY |
1 |
0.0003 |
| 220 |
NASAL DRYNESS |
2 |
0.0003 |
| 221 |
BREAST CANCER RECURRENT |
1 |
0.0003 |
| 222 |
TESTICULAR PAIN |
1 |
0.0003 |
| 223 |
PNEUMONIA VIRAL |
1 |
0.0003 |
| 224 |
DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0003 |
| 225 |
APPLICATION SITE ERYTHEMA |
8 |
0.0003 |
| 226 |
INFUSION SITE HAEMORRHAGE |
1 |
0.0003 |
| 227 |
WALKING AID USER |
2 |
0.0003 |
| 228 |
OTITIS MEDIA |
1 |
0.0003 |
| 229 |
CONTRAINDICATED PRODUCT ADMINISTERED |
9 |
0.0003 |
| 230 |
SUPRAVENTRICULAR EXTRASYSTOLES |
1 |
0.0003 |
| 231 |
LIMB DISCOMFORT |
9 |
0.0003 |
| 232 |
HAIR GROWTH ABNORMAL |
2 |
0.0003 |
| 233 |
EYE DISCHARGE |
3 |
0.0003 |
| 234 |
EAR PRURITUS |
1 |
0.0003 |
| 235 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
3 |
0.0003 |
| 236 |
PRURITUS |
107 |
0.0003 |
| 237 |
THERAPEUTIC RESPONSE SHORTENED |
9 |
0.0003 |
| 238 |
TENDON INJURY |
1 |
0.0003 |
| 239 |
SKIN INFECTION |
3 |
0.0003 |
| 240 |
THROAT CLEARING |
1 |
0.0003 |
| 241 |
MATERNAL EXPOSURE TIMING UNSPECIFIED |
1 |
0.0003 |
| 242 |
TONGUE OEDEMA |
1 |
0.0003 |
| 243 |
PARANASAL SINUS HYPERSECRETION |
1 |
0.0003 |
| 244 |
SYSTEMIC INFLAMMATORY RESPONSE SYNDROME |
1 |
0.0003 |
| 245 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 246 |
OESOPHAGEAL DISORDER |
1 |
0.0003 |
| 247 |
RHINOVIRUS INFECTION |
1 |
0.0003 |
| 248 |
VULVOVAGINAL MYCOTIC INFECTION |
1 |
0.0003 |
| 249 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 250 |
NECK PAIN |
14 |
0.0003 |
| 251 |
BLEPHARITIS |
1 |
0.0002 |
| 252 |
RHINITIS |
2 |
0.0002 |
| 253 |
INTERNATIONAL NORMALISED RATIO DECREASED |
1 |
0.0002 |
| 254 |
PSORIATIC ARTHROPATHY |
10 |
0.0002 |
| 255 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
1 |
0.0002 |
| 256 |
HAIR DISORDER |
2 |
0.0002 |
| 257 |
THYROID FUNCTION TEST ABNORMAL |
1 |
0.0002 |
| 258 |
INFUSION SITE ERYTHEMA |
2 |
0.0002 |
| 259 |
ABSCESS LIMB |
1 |
0.0002 |
| 260 |
INTERVERTEBRAL DISC DISORDER |
1 |
0.0002 |
| 261 |
SCAR |
4 |
0.0002 |
| 262 |
DEVICE OPERATIONAL ISSUE |
1 |
0.0002 |
| 263 |
HORDEOLUM |
1 |
0.0002 |
| 264 |
PYELONEPHRITIS |
2 |
0.0002 |
| 265 |
DIVERTICULUM INTESTINAL |
1 |
0.0002 |
| 266 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 267 |
MELANOCYTIC NAEVUS |
1 |
0.0002 |
| 268 |
PARONYCHIA |
1 |
0.0002 |
| 269 |
VULVOVAGINAL DISCOMFORT |
1 |
0.0002 |
| 270 |
WHEELCHAIR USER |
1 |
0.0002 |
| 271 |
RHINITIS ALLERGIC |
1 |
0.0002 |
| 272 |
DRY EYE |
11 |
0.0002 |
| 273 |
BUNDLE BRANCH BLOCK RIGHT |
1 |
0.0002 |
| 274 |
ROSACEA |
1 |
0.0002 |
| 275 |
FEELING OF DESPAIR |
1 |
0.0002 |
| 276 |
SKIN TIGHTNESS |
1 |
0.0002 |
| 277 |
SQUAMOUS CELL CARCINOMA |
2 |
0.0002 |
| 278 |
BLOOD PROLACTIN INCREASED |
1 |
0.0002 |
| 279 |
SEASONAL ALLERGY |
3 |
0.0002 |
| 280 |
SKIN ABRASION |
1 |
0.0002 |
| 281 |
HAEMORRHOIDAL HAEMORRHAGE |
1 |
0.0002 |
| 282 |
BREATH SOUNDS ABNORMAL |
1 |
0.0002 |
| 283 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 284 |
RASH MACULAR |
7 |
0.0002 |
| 285 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 286 |
LACRIMATION INCREASED |
6 |
0.0002 |
| 287 |
THERAPEUTIC RESPONSE DECREASED |
12 |
0.0002 |
| 288 |
VULVOVAGINAL PRURITUS |
1 |
0.0002 |
| 289 |
DRY THROAT |
2 |
0.0002 |
| 290 |
PRODUCT COLOUR ISSUE |
1 |
0.0002 |
| 291 |
BASAL CELL CARCINOMA |
3 |
0.0002 |
| 292 |
INJECTION SITE DISCOMFORT |
2 |
0.0002 |
| 293 |
RESPIRATORY TRACT CONGESTION |
3 |
0.0002 |
| 294 |
RASH ERYTHEMATOUS |
9 |
0.0002 |
| 295 |
EYE SWELLING |
7 |
0.0002 |
| 296 |
ANAL FISTULA |
1 |
0.0002 |
| 297 |
FOOD POISONING |
1 |
0.0002 |
| 298 |
PRODUCT RESIDUE PRESENT |
1 |
0.0002 |
| 299 |
SKIN LACERATION |
2 |
0.0002 |
| 300 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
1 |
0.0002 |
| 301 |
TIC |
1 |
0.0002 |
| 302 |
SKIN BURNING SENSATION |
13 |
0.0002 |
| 303 |
CHOKING SENSATION |
1 |
0.0002 |
| 304 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
1 |
0.0002 |
| 305 |
SKIN DISORDER |
6 |
0.0002 |
| 306 |
PRODUCT LEAKAGE |
1 |
0.0002 |
| 307 |
OCULAR DISCOMFORT |
2 |
0.0002 |
| 308 |
COLECTOMY |
1 |
0.0002 |
| 309 |
PERIORBITAL SWELLING |
1 |
0.0002 |
| 310 |
APPLICATION SITE PRURITUS |
4 |
0.0002 |
| 311 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 312 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 313 |
ERYTHEMA |
36 |
0.0002 |
| 314 |
MICTURITION URGENCY |
2 |
0.0002 |
| 315 |
CARDIAC VALVE DISEASE |
1 |
0.0002 |
| 316 |
CORONARY ARTERY BYPASS |
1 |
0.0002 |
| 317 |
MOUTH SWELLING |
1 |
0.0002 |
| 318 |
SOCIAL AVOIDANT BEHAVIOUR |
1 |
0.0002 |
| 319 |
BLOOD CHOLESTEROL INCREASED |
8 |
0.0002 |
| 320 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 321 |
SLEEP DISORDER |
12 |
0.0002 |
| 322 |
HYPERCHLORHYDRIA |
1 |
0.0002 |
| 323 |
OCULAR HYPERAEMIA |
8 |
0.0002 |
| 324 |
PLATELET COUNT ABNORMAL |
1 |
0.0002 |
| 325 |
CONJUNCTIVITIS |
3 |
0.0002 |
| 326 |
SCOLIOSIS |
1 |
0.0002 |
| 327 |
PSORIASIS |
21 |
0.0002 |
| 328 |
SWELLING OF EYELID |
1 |
0.0002 |
| 329 |
INFUSION SITE SWELLING |
1 |
0.0002 |
| 330 |
BLEPHAROSPASM |
1 |
0.0002 |
| 331 |
PHOTOPSIA |
1 |
0.0002 |
| 332 |
EYE IRRITATION |
9 |
0.0002 |
| 333 |
THERAPEUTIC RESPONSE UNEXPECTED |
7 |
0.0002 |
| 334 |
EXPOSURE VIA SKIN CONTACT |
4 |
0.0002 |
| 335 |
APPLICATION SITE VESICLES |
1 |
0.0002 |
| 336 |
HERPES SIMPLEX |
1 |
0.0002 |
| 337 |
ORAL HERPES |
3 |
0.0002 |
| 338 |
TENDON DISORDER |
1 |
0.0002 |
| 339 |
ARTHRITIS |
12 |
0.0002 |
| 340 |
SOMNAMBULISM |
1 |
0.0002 |
| 341 |
TOOTH INFECTION |
2 |
0.0002 |
| 342 |
SARS-COV-2 TEST POSITIVE |
2 |
0.0002 |
| 343 |
ARTERIOSCLEROSIS CORONARY ARTERY |
1 |
0.0002 |
| 344 |
SKIN MASS |
1 |
0.0001 |
| 345 |
SINUS CONGESTION |
2 |
0.0001 |
| 346 |
THROAT TIGHTNESS |
4 |
0.0001 |
| 347 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 348 |
EYE MOVEMENT DISORDER |
1 |
0.0001 |
| 349 |
PRODUCT PREPARATION ERROR |
3 |
0.0001 |
| 350 |
ONYCHOCLASIS |
1 |
0.0001 |
| 351 |
LARGE INTESTINE POLYP |
1 |
0.0001 |
| 352 |
HYPERKALAEMIA |
5 |
0.0001 |
| 353 |
SKIN REACTION |
2 |
0.0001 |
| 354 |
PAPULE |
1 |
0.0001 |
| 355 |
THERMAL BURN |
1 |
0.0001 |
| 356 |
PRURITUS GENERALISED |
3 |
0.0001 |
| 357 |
PARAESTHESIA ORAL |
2 |
0.0001 |
| 358 |
SWELLING FACE |
9 |
0.0001 |
| 359 |
RASH |
60 |
0.0001 |
| 360 |
LIQUID PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 361 |
INTENTIONAL UNDERDOSE |
1 |
0.0001 |
| 362 |
MAJOR DEPRESSION |
1 |
0.0001 |
| 363 |
SENSITIVE SKIN |
1 |
0.0001 |
| 364 |
DRUG EFFECT LESS THAN EXPECTED |
2 |
0.0001 |
| 365 |
ARTHROPOD BITE |
1 |
0.0001 |
| 366 |
SUNBURN |
1 |
0.0001 |
| 367 |
HYDRONEPHROSIS |
1 |
0.0001 |
| 368 |
PEMPHIGOID |
1 |
0.0001 |
| 369 |
TENDON PAIN |
1 |
0.0001 |
| 370 |
PRODUCT AVAILABILITY ISSUE |
3 |
0.0001 |
| 371 |
ILL-DEFINED DISORDER |
8 |
0.0001 |
| 372 |
LIPASE INCREASED |
1 |
0.0001 |
| 373 |
DEVICE RELATED INFECTION |
2 |
0.0001 |
| 374 |
FOOD ALLERGY |
1 |
0.0001 |
| 375 |
CONCUSSION |
1 |
0.0001 |
| 376 |
RASH PRURITIC |
7 |
0.0001 |
| 377 |
PULMONARY HAEMORRHAGE |
1 |
0.0001 |
| 378 |
MULTIPLE ALLERGIES |
1 |
0.0001 |
| 379 |
AFFECTIVE DISORDER |
1 |
0.0001 |
| 380 |
HEAD INJURY |
4 |
0.0001 |
| 381 |
ILLNESS |
13 |
0.0001 |
| 382 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 383 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 384 |
CYSTITIS |
4 |
0.0001 |
| 385 |
ABSCESS |
2 |
0.0001 |
| 386 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 387 |
OBSESSIVE-COMPULSIVE DISORDER |
1 |
0.0001 |
| 388 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 389 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 390 |
DECUBITUS ULCER |
1 |
0.0001 |
| 391 |
EYE DISORDER |
4 |
0.0001 |
| 392 |
UPPER-AIRWAY COUGH SYNDROME |
1 |
0.0001 |
| 393 |
EXPIRED PRODUCT ADMINISTERED |
4 |
0.0001 |
| 394 |
VIRAL INFECTION |
4 |
0.0001 |
| 395 |
SKIN PLAQUE |
1 |
0.0001 |
| 396 |
HEMIPARESIS |
2 |
0.0001 |
| 397 |
VITAMIN D DECREASED |
1 |
0.0001 |
| 398 |
PERIPHERAL SWELLING |
18 |
0.0001 |
| 399 |
PSEUDOMONAS INFECTION |
1 |
0.0001 |
| 400 |
MUSCLE STRAIN |
1 |
0.0001 |
| 401 |
RESPIRATORY TRACT INFECTION |
3 |
0.0001 |
| 402 |
GROIN PAIN |
1 |
0.0001 |
| 403 |
LYMPHOCYTE COUNT DECREASED |
2 |
0.0001 |
| 404 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 405 |
LYMPHADENOPATHY |
4 |
0.0001 |
| 406 |
FACIAL PAIN |
1 |
0.0001 |
| 407 |
GASTROINTESTINAL INFECTION |
1 |
0.0001 |
| 408 |
GASTROENTERITIS VIRAL |
2 |
0.0001 |
| 409 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 410 |
LIP DRY |
1 |
0.0001 |
| 411 |
PNEUMONIA BACTERIAL |
1 |
0.0001 |
| 412 |
INCREASED TENDENCY TO BRUISE |
1 |
0.0001 |
| 413 |
TREATMENT FAILURE |
9 |
0.0001 |
| 414 |
OVARIAN CANCER |
1 |
0.0001 |
| 415 |
NERVE COMPRESSION |
1 |
0.0001 |
| 416 |
INTERVERTEBRAL DISC DEGENERATION |
1 |
0.0001 |
| 417 |
BLISTER |
6 |
0.0001 |
| 418 |
FLANK PAIN |
1 |
0.0001 |
| 419 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
19 |
0.0001 |
| 420 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 421 |
PRODUCT USE IN UNAPPROVED INDICATION |
26 |
0.0001 |
| 422 |
EYE INFLAMMATION |
1 |
0.0001 |
| 423 |
POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME |
1 |
0.0001 |
| 424 |
SUPRAVENTRICULAR TACHYCARDIA |
1 |
0.0001 |
| 425 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 426 |
EAR PAIN |
2 |
0.0001 |
| 427 |
AUTOIMMUNE DISORDER |
1 |
0.0001 |
| 428 |
DISABILITY |
2 |
0.0001 |
| 429 |
INJECTION SITE PAIN |
31 |
0.0001 |
| 430 |
SINUS DISORDER |
2 |
0.0001 |
| 431 |
SALIVARY HYPERSECRETION |
1 |
0.0001 |
| 432 |
BURNING SENSATION |
7 |
0.0001 |
| 433 |
CELLULITIS |
5 |
0.0001 |
| 434 |
EMPHYSEMA |
1 |
0.0001 |
| 435 |
HYPOTHERMIA |
1 |
0.0001 |
| 436 |
INJECTION SITE RASH |
3 |
0.0001 |
| 437 |
INITIAL INSOMNIA |
1 |
0.0001 |
| 438 |
SWOLLEN TONGUE |
3 |
0.0001 |
| 439 |
PULMONARY HYPERTENSION |
2 |
0.0001 |
| 440 |
HAEMORRHAGE |
10 |
0.0001 |
| 441 |
KNEE ARTHROPLASTY |
2 |
0.0001 |
| 442 |
EATING DISORDER |
2 |
0.0001 |
| 443 |
HEREDITARY ANGIOEDEMA |
1 |
0.0001 |
| 444 |
SKIN CANCER |
2 |
0.0001 |
| 445 |
ALOPECIA |
18 |
0.0001 |
| 446 |
INJECTION SITE SWELLING |
7 |
0.0001 |
| 447 |
NERVE INJURY |
1 |
0.0001 |
| 448 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 449 |
EYE INFECTION |
1 |
0.0001 |
| 450 |
STATUS EPILEPTICUS |
1 |
0.0001 |
| 451 |
HEART RATE IRREGULAR |
2 |
0.0001 |
| 452 |
REBOUND EFFECT |
1 |
0.0001 |
| 453 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 454 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 455 |
SKIN DISCOLOURATION |
4 |
0.0001 |
| 456 |
HERPES ZOSTER |
5 |
0.0001 |
| 457 |
NEOPLASM |
1 |
0.0001 |
| 458 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 459 |
MUSCLE TWITCHING |
2 |
0.0001 |
| 460 |
MADAROSIS |
1 |
0.0001 |
| 461 |
ELECTROLYTE IMBALANCE |
1 |
0.0001 |
| 462 |
PRODUCT USE ISSUE |
16 |
0.0001 |
| 463 |
NASAL CONGESTION |
5 |
0.0001 |
| 464 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
6 |
0.0001 |
| 465 |
PRODUCT PRESCRIBING ERROR |
2 |
0.0001 |
| 466 |
ACCIDENT |
1 |
0.0001 |
| 467 |
HYPERLIPIDAEMIA |
1 |
0.0001 |
| 468 |
THYROID CANCER |
1 |
0.0001 |
| 469 |
ADRENAL INSUFFICIENCY |
1 |
0.0001 |
| 470 |
NO THERAPEUTIC RESPONSE |
1 |
0.0001 |
| 471 |
DISCOMFORT |
5 |
0.0001 |
| 472 |
CYTOPENIA |
1 |
0.0001 |
| 473 |
ENCEPHALOPATHY |
2 |
0.0001 |
| 474 |
MUSCLE SPASTICITY |
1 |
0.0001 |
| 475 |
CARDIOMEGALY |
1 |
0.0001 |
| 476 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 477 |
INJECTION SITE MASS |
3 |
0.0001 |
| 478 |
TENDON RUPTURE |
1 |
0.0001 |
| 479 |
HYPERCALCAEMIA |
1 |
0.0001 |
| 480 |
THROMBOCYTOPENIA |
9 |
0.0001 |
| 481 |
ASTHMA |
9 |
0.0001 |
| 482 |
DERMATITIS ALLERGIC |
1 |
0.0001 |
| 483 |
BRAIN OEDEMA |
1 |
0.0001 |
| 484 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 485 |
ROTATOR CUFF SYNDROME |
1 |
0.0001 |
| 486 |
INFUSION SITE PAIN |
1 |
0.0001 |
| 487 |
URTICARIA |
13 |
0.0001 |
| 488 |
ANAPHYLACTIC SHOCK |
2 |
0.0001 |
| 489 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
1 |
0.0001 |
| 490 |
SKIN ULCER |
2 |
0.0001 |
| 491 |
RHINORRHOEA |
5 |
0.0001 |
| 492 |
INJECTION SITE INDURATION |
1 |
0.0001 |
| 493 |
NODULE |
1 |
0.0001 |
| 494 |
PRODUCT DOSE OMISSION |
5 |
0.0001 |
| 495 |
BEDRIDDEN |
1 |
0.0001 |
| 496 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 497 |
OROPHARYNGEAL PAIN |
7 |
0.0001 |
| 498 |
EAR INFECTION |
2 |
0.0001 |
| 499 |
EYE HAEMORRHAGE |
1 |
0.0001 |
| 500 |
SWELLING |
7 |
0.0001 |
| 501 |
COVID-19 |
13 |
0.0001 |
| 502 |
SKIN LESION |
2 |
0.0001 |
| 503 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
4 |
0.0001 |
| 504 |
CONDITION AGGRAVATED |
22 |
0.0001 |
| 505 |
FEELING COLD |
2 |
0.0001 |
| 506 |
HUNGER |
1 |
0.0001 |
| 507 |
APHONIA |
1 |
0.0001 |
| 508 |
WOUND |
2 |
0.0001 |
| 509 |
MASS |
1 |
0.0001 |
| 510 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 511 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 512 |
PRODUCT DOSE OMISSION IN ERROR |
2 |
0.0001 |
| 513 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 514 |
URINARY TRACT INFECTION |
12 |
0.0001 |
| 515 |
HYPERSENSITIVITY |
13 |
0.0001 |
| 516 |
PARALYSIS |
1 |
0.0001 |
| 517 |
ANOSMIA |
1 |
0.0001 |
| 518 |
FLUID OVERLOAD |
1 |
0.0001 |
| 519 |
INTENTIONAL PRODUCT MISUSE |
6 |
0.0001 |
| 520 |
DYSPHONIA |
4 |
0.0001 |
| 521 |
SINUSITIS |
7 |
0.0001 |
| 522 |
CATARACT |
4 |
0.0001 |
| 523 |
EPISTAXIS |
5 |
0.0001 |
| 524 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 525 |
OSTEOPENIA |
1 |
0.0001 |
| 526 |
BLOOD PRESSURE INCREASED |
10 |
0.0001 |
| 527 |
INSURANCE ISSUE |
1 |
0.0001 |
| 528 |
THYROID DISORDER |
1 |
0.0001 |
| 529 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 530 |
TENDONITIS |
1 |
0.0001 |
| 531 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 532 |
PRODUCT USE COMPLAINT |
1 |
0.0001 |
| 533 |
PNEUMOTHORAX |
1 |
0.0001 |
| 534 |
ULCER |
1 |
0.0001 |
| 535 |
PRODUCTIVE COUGH |
3 |
0.0001 |
| 536 |
INFLUENZA |
7 |
0.0001 |
| 537 |
SCIATICA |
1 |
0.0001 |
| 538 |
HYPOTHYROIDISM |
2 |
0.0001 |
| 539 |
METABOLIC ACIDOSIS |
2 |
0.0001 |
| 540 |
BACK DISORDER |
1 |
0.0001 |
| 541 |
METASTASES TO BONE |
1 |
0.0001 |
| 542 |
STAPHYLOCOCCAL INFECTION |
2 |
0.0001 |
| 543 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 544 |
BACK PAIN |
14 |
0.0001 |
| 545 |
CYTOMEGALOVIRUS INFECTION |
1 |
0.0001 |
| 546 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 547 |
FACE OEDEMA |
1 |
0.0001 |
| 548 |
CANDIDA INFECTION |
1 |
0.0001 |
| 549 |
FLUID RETENTION |
3 |
0.0001 |
| 550 |
INFLAMMATION |
3 |
0.0001 |
| 551 |
PRODUCT DOSE OMISSION ISSUE |
17 |
0.0001 |
| 552 |
ORTHOSTATIC HYPOTENSION |
1 |
0.0001 |
| 553 |
LOCAL SWELLING |
1 |
0.0001 |
| 554 |
AMENORRHOEA |
1 |
0.0001 |
| 555 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 556 |
ISCHAEMIC STROKE |
1 |
0.0001 |
| 557 |
THIRST |
1 |
0.0001 |
| 558 |
GOUT |
1 |
0.0001 |
| 559 |
PAIN |
34 |
0.0001 |
| 560 |
LEUKOCYTOSIS |
1 |
0.0001 |
| 561 |
TOOTHACHE |
1 |
0.0001 |
| 562 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 563 |
BONE DISORDER |
1 |
0.0001 |
| 564 |
RESPIRATORY FAILURE |
4 |
0.0001 |
| 565 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 566 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
1 |
0.0001 |
| 567 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 568 |
MIDDLE INSOMNIA |
1 |
0.0001 |
| 569 |
PHOTOPHOBIA |
1 |
0.0001 |
| 570 |
DYSARTHRIA |
2 |
0.0001 |
| 571 |
DYSPNOEA EXERTIONAL |
2 |
0.0001 |
| 572 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 573 |
PROTEINURIA |
1 |
0.0001 |
| 574 |
SLEEP APNOEA SYNDROME |
1 |
0.0001 |
| 575 |
MIGRAINE |
5 |
0.0001 |
| 576 |
INCREASED APPETITE |
1 |
0.0001 |
| 577 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 578 |
LOWER LIMB FRACTURE |
1 |
0.0001 |
| 579 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 580 |
HERNIA |
1 |
0.0001 |
| 581 |
PRESCRIBED OVERDOSE |
1 |
0.0001 |
| 582 |
HAEMORRHOIDS |
1 |
0.0001 |
| 583 |
CHOKING |
1 |
0.0001 |
| 584 |
SURGERY |
3 |
0.0001 |
| 585 |
HEADACHE |
32 |
0.0001 |
| 586 |
PAIN IN EXTREMITY |
15 |
0.0001 |
| 587 |
WHEEZING |
3 |
0.0001 |
| 588 |
ARTHRALGIA |
21 |
0.0001 |
| 589 |
BLOOD PRESSURE ABNORMAL |
1 |
0.0001 |
| 590 |
UPPER LIMB FRACTURE |
1 |
0.0001 |
| 591 |
WEIGHT DECREASED |
14 |
0.0001 |
| 592 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 593 |
COUGH |
14 |
0.0000 |
| 594 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0000 |
| 595 |
INTENTIONAL SELF-INJURY |
1 |
0.0000 |
| 596 |
SUICIDE ATTEMPT |
3 |
0.0000 |
| 597 |
TASTE DISORDER |
1 |
0.0000 |
| 598 |
WEIGHT INCREASED |
11 |
0.0000 |
| 599 |
ALANINE AMINOTRANSFERASE INCREASED |
3 |
0.0000 |
| 600 |
LUNG NEOPLASM MALIGNANT |
2 |
0.0000 |
| 601 |
RIB FRACTURE |
1 |
0.0000 |
| 602 |
MOUTH ULCERATION |
1 |
0.0000 |
| 603 |
IRRITABLE BOWEL SYNDROME |
1 |
0.0000 |
| 604 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 605 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 606 |
DEEP VEIN THROMBOSIS |
3 |
0.0000 |
| 607 |
MENTAL DISORDER |
2 |
0.0000 |
| 608 |
BLOOD CREATININE INCREASED |
3 |
0.0000 |
| 609 |
PRODUCT PRESCRIBING ISSUE |
1 |
0.0000 |
| 610 |
INTERVERTEBRAL DISC PROTRUSION |
1 |
0.0000 |
| 611 |
DRUG INEFFECTIVE |
60 |
0.0000 |
| 612 |
TOOTH DISORDER |
1 |
0.0000 |
| 613 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 614 |
ORAL PAIN |
1 |
0.0000 |
| 615 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
2 |
0.0000 |
| 616 |
GASTROINTESTINAL DISORDER |
4 |
0.0000 |
| 617 |
RASH PAPULAR |
1 |
0.0000 |
| 618 |
THROAT IRRITATION |
2 |
0.0000 |
| 619 |
CHROMATURIA |
1 |
0.0000 |
| 620 |
SUICIDAL IDEATION |
4 |
0.0000 |
| 621 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 622 |
PYREXIA |
15 |
0.0000 |
| 623 |
UPPER RESPIRATORY TRACT INFECTION |
2 |
0.0000 |
| 624 |
PERICARDIAL EFFUSION |
1 |
0.0000 |
| 625 |
CARDIAC DISORDER |
4 |
0.0000 |
| 626 |
THERAPY INTERRUPTED |
3 |
0.0000 |
| 627 |
MOBILITY DECREASED |
3 |
0.0000 |
| 628 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 629 |
LUNG DISORDER |
2 |
0.0000 |
| 630 |
LEUKOPENIA |
2 |
0.0000 |
| 631 |
THERAPY CESSATION |
2 |
0.0000 |
| 632 |
ACCIDENTAL EXPOSURE TO PRODUCT |
4 |
0.0000 |
| 633 |
HAEMATOMA |
1 |
0.0000 |
| 634 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
2 |
0.0000 |
| 635 |
PARAESTHESIA |
6 |
0.0000 |
| 636 |
JOINT STIFFNESS |
1 |
0.0000 |
| 637 |
ANHEDONIA |
1 |
0.0000 |
| 638 |
GASTRITIS |
1 |
0.0000 |
| 639 |
INJECTION SITE BRUISING |
3 |
0.0000 |
| 640 |
INJECTION SITE HAEMORRHAGE |
3 |
0.0000 |
| 641 |
JAUNDICE |
1 |
0.0000 |
| 642 |
DRY MOUTH |
3 |
0.0000 |
| 643 |
PALLOR |
1 |
0.0000 |
| 644 |
MOOD ALTERED |
1 |
0.0000 |
| 645 |
TREATMENT NONCOMPLIANCE |
2 |
0.0000 |
| 646 |
RESPIRATORY DISTRESS |
1 |
0.0000 |
| 647 |
ABNORMAL DREAMS |
1 |
0.0000 |
| 648 |
ANAPHYLACTIC REACTION |
2 |
0.0000 |
| 649 |
DIVERTICULITIS |
1 |
0.0000 |
| 650 |
ARTHROPATHY |
2 |
0.0000 |
| 651 |
SEPSIS |
4 |
0.0000 |
| 652 |
HAEMOPTYSIS |
1 |
0.0000 |
| 653 |
RENAL IMPAIRMENT |
3 |
0.0000 |
| 654 |
EYE PAIN |
2 |
0.0000 |
| 655 |
MYALGIA |
6 |
0.0000 |
| 656 |
FLATULENCE |
2 |
0.0000 |
| 657 |
ANGINA PECTORIS |
1 |
0.0000 |
| 658 |
HYPERSOMNIA |
1 |
0.0000 |
| 659 |
LETHARGY |
2 |
0.0000 |
| 660 |
DYSSTASIA |
1 |
0.0000 |
| 661 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 662 |
BONE PAIN |
2 |
0.0000 |
| 663 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 664 |
URINARY INCONTINENCE |
1 |
0.0000 |
| 665 |
DYSPNOEA |
19 |
0.0000 |
| 666 |
HYPOAESTHESIA |
5 |
0.0000 |
| 667 |
IRRITABILITY |
2 |
0.0000 |
| 668 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 669 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 670 |
VERTIGO |
2 |
0.0000 |
| 671 |
ACUTE KIDNEY INJURY |
5 |
0.0000 |
| 672 |
CHEST PAIN |
6 |
0.0000 |
| 673 |
MALAISE |
14 |
0.0000 |
| 674 |
DRUG-INDUCED LIVER INJURY |
1 |
0.0000 |
| 675 |
MOVEMENT DISORDER |
1 |
0.0000 |
| 676 |
DIARRHOEA |
20 |
0.0000 |
| 677 |
INCORRECT DOSE ADMINISTERED |
7 |
0.0000 |
| 678 |
INSOMNIA |
8 |
0.0000 |
| 679 |
LIP SWELLING |
1 |
0.0000 |
| 680 |
DEHYDRATION |
4 |
0.0000 |
| 681 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 682 |
VOMITING |
14 |
0.0000 |
| 683 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 684 |
FLUSHING |
3 |
0.0000 |
| 685 |
HAEMATURIA |
1 |
0.0000 |
| 686 |
VISION BLURRED |
4 |
0.0000 |
| 687 |
DEVICE USE ERROR |
1 |
0.0000 |
| 688 |
HYPOXIA |
1 |
0.0000 |
| 689 |
ANXIETY |
8 |
0.0000 |
| 690 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 691 |
NAUSEA |
22 |
0.0000 |
| 692 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 693 |
NO ADVERSE EVENT |
5 |
0.0000 |
| 694 |
CONSTIPATION |
6 |
0.0000 |
| 695 |
HYPERGLYCAEMIA |
1 |
0.0000 |
| 696 |
PANIC ATTACK |
1 |
0.0000 |
| 697 |
UNDERDOSE |
2 |
0.0000 |
| 698 |
MUSCLE SPASMS |
5 |
0.0000 |
| 699 |
AGITATION |
2 |
0.0000 |
| 700 |
DYSURIA |
1 |
0.0000 |
| 701 |
HOT FLUSH |
2 |
0.0000 |
| 702 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 703 |
GAIT DISTURBANCE |
5 |
0.0000 |
| 704 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 705 |
HOSPITALISATION |
4 |
0.0000 |
| 706 |
DECREASED APPETITE |
6 |
0.0000 |
| 707 |
CHILLS |
3 |
0.0000 |
| 708 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
1 |
0.0000 |
| 709 |
DRUG INTERACTION |
4 |
0.0000 |
| 710 |
OFF LABEL USE |
22 |
0.0000 |
| 711 |
CARDIAC FAILURE CONGESTIVE |
2 |
0.0000 |
| 712 |
GASTROOESOPHAGEAL REFLUX DISEASE |
2 |
0.0000 |
| 713 |
EXTRA DOSE ADMINISTERED |
1 |
0.0000 |
| 714 |
DYSKINESIA |
1 |
0.0000 |
| 715 |
INFLUENZA LIKE ILLNESS |
2 |
0.0000 |
| 716 |
VISUAL IMPAIRMENT |
3 |
0.0000 |
| 717 |
DIZZINESS |
12 |
0.0000 |
| 718 |
RHABDOMYOLYSIS |
1 |
0.0000 |
| 719 |
POLLAKIURIA |
1 |
0.0000 |
| 720 |
GASTROINTESTINAL HAEMORRHAGE |
2 |
0.0000 |
| 721 |
CARDIO-RESPIRATORY ARREST |
1 |
0.0000 |
| 722 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 723 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 724 |
WITHDRAWAL SYNDROME |
1 |
0.0000 |
| 725 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 726 |
RECTAL HAEMORRHAGE |
1 |
0.0000 |
| 727 |
HYPOACUSIS |
1 |
0.0000 |
| 728 |
BALANCE DISORDER |
2 |
0.0000 |
| 729 |
FATIGUE |
18 |
0.0000 |
| 730 |
MUSCULOSKELETAL STIFFNESS |
2 |
0.0000 |
| 731 |
ANGIOEDEMA |
1 |
0.0000 |
| 732 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 733 |
PRODUCT QUALITY ISSUE |
3 |
0.0000 |
| 734 |
PNEUMONIA |
7 |
0.0000 |
| 735 |
RENAL DISORDER |
1 |
0.0000 |
| 736 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 737 |
ARRHYTHMIA |
1 |
0.0000 |
| 738 |
FALL |
7 |
0.0000 |
| 739 |
NEUROPATHY PERIPHERAL |
2 |
0.0000 |
| 740 |
MULTIPLE SCLEROSIS |
1 |
0.0000 |
| 741 |
INFECTION |
3 |
0.0000 |
| 742 |
INTERSTITIAL LUNG DISEASE |
1 |
0.0000 |
| 743 |
DYSPEPSIA |
2 |
0.0000 |
| 744 |
HEART RATE INCREASED |
2 |
0.0000 |
| 745 |
SOMNOLENCE |
4 |
0.0000 |
| 746 |
CHEST DISCOMFORT |
2 |
0.0000 |
| 747 |
ABDOMINAL DISTENSION |
2 |
0.0000 |
| 748 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 749 |
SPEECH DISORDER |
1 |
0.0000 |
| 750 |
PANCREATITIS |
1 |
0.0000 |
| 751 |
HYPERTENSION |
4 |
0.0000 |
| 752 |
PLATELET COUNT DECREASED |
2 |
0.0000 |
| 753 |
ASTHENIA |
7 |
0.0000 |
| 754 |
DRUG EFFECT DECREASED |
1 |
0.0000 |
| 755 |
OEDEMA |
1 |
0.0000 |
| 756 |
HYPONATRAEMIA |
1 |
0.0000 |
| 757 |
CONVULSION |
1 |
0.0000 |
| 758 |
SEIZURE |
2 |
0.0000 |
| 759 |
ABDOMINAL PAIN |
4 |
0.0000 |
| 760 |
PALPITATIONS |
2 |
0.0000 |
| 761 |
FEELING ABNORMAL |
4 |
0.0000 |
| 762 |
JOINT SWELLING |
2 |
0.0000 |
| 763 |
STOMATITIS |
1 |
0.0000 |
| 764 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 765 |
OEDEMA PERIPHERAL |
2 |
0.0000 |
| 766 |
FEELING HOT |
1 |
0.0000 |
| 767 |
NASOPHARYNGITIS |
3 |
0.0000 |
| 768 |
INJECTION SITE ERYTHEMA |
2 |
0.0000 |
| 769 |
ANAEMIA |
3 |
0.0000 |
| 770 |
LOSS OF CONSCIOUSNESS |
2 |
0.0000 |
| 771 |
HYPERHIDROSIS |
2 |
0.0000 |
| 772 |
AMNESIA |
1 |
0.0000 |
| 773 |
BLOOD PRESSURE DECREASED |
1 |
0.0000 |
| 774 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 775 |
HEPATIC ENZYME INCREASED |
1 |
0.0000 |
| 776 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 777 |
MEMORY IMPAIRMENT |
2 |
0.0000 |
| 778 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 779 |
DEVICE MALFUNCTION |
1 |
0.0000 |
| 780 |
INJURY |
1 |
0.0000 |
| 781 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 782 |
BRONCHITIS |
1 |
0.0000 |
| 783 |
DYSGEUSIA |
1 |
0.0000 |
| 784 |
HALLUCINATION |
1 |
0.0000 |
| 785 |
ACNE |
1 |
0.0000 |
| 786 |
DEPRESSION |
3 |
0.0000 |
| 787 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 788 |
DIABETES MELLITUS |
1 |
0.0000 |
| 789 |
THROMBOSIS |
1 |
0.0000 |
| 790 |
FOETAL EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 791 |
CARDIAC ARREST |
1 |
0.0000 |
| 792 |
PRODUCT STORAGE ERROR |
1 |
0.0000 |
| 793 |
DEVICE ISSUE |
1 |
0.0000 |
| 794 |
BREAST CANCER |
1 |
0.0000 |
| 795 |
DYSPHAGIA |
1 |
0.0000 |
| 796 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 797 |
CONTUSION |
1 |
0.0000 |
| 798 |
ATRIAL FIBRILLATION |
1 |
0.0000 |
| 799 |
SYNCOPE |
1 |
0.0000 |
| 800 |
MALIGNANT NEOPLASM PROGRESSION |
1 |
0.0000 |
| 801 |
OVERDOSE |
2 |
0.0000 |
| 802 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 803 |
RHEUMATOID ARTHRITIS |
1 |
0.0000 |
| 804 |
MUSCULAR WEAKNESS |
1 |
0.0000 |
| 805 |
DISEASE PROGRESSION |
1 |
0.0000 |
| 806 |
RENAL FAILURE |
1 |
0.0000 |
| 807 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 808 |
DRUG DOSE OMISSION |
1 |
0.0000 |
| 809 |
TREMOR |
1 |
0.0000 |
| 810 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 811 |
CEREBROVASCULAR ACCIDENT |
1 |
0.0000 |
| 812 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 813 |
BLOOD GLUCOSE INCREASED |
1 |
0.0000 |
| 814 |
HYPOTENSION |
1 |
0.0000 |
| 815 |
DEATH |
4 |
0.0000 |